Sign In
Buy VTGN
$0.229
-0.0108 (-4.50%)
At Close: Jul 17, 2026
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence
10:00am, Monday, 13'th May 2024
The hype train is always talking about meme stocks set for a rebound on Reddit (NASDAQ: RDDT ). I try my best to avoid these large echo chambers of misinformation.
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
08:30am, Tuesday, 07'th May 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals a
PRISM MarketView – Weekly Market Report – April 26, 2024
02:39pm, Friday, 26'th Apr 2024
PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 – PRISM MarketView – Equities were higher through th
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
08:30am, Thursday, 25'th Apr 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals a
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
07:13am, Friday, 19'th Apr 2024
If you're searching for stocks under $15, look no further. These seven offerings, all priced below $15, present a unique opportunity for individual investors to profit from future development.
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
01:28pm, Tuesday, 09'th Apr 2024
Finding possibilities in investing frequently depends on finding companies attached to rapid expansion and value generation. Examine these three prospects, each selling at less than $10 per share and
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
08:30am, Tuesday, 09'th Apr 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapi
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
10:00am, Sunday, 31'st Mar 2024
Finding undiscovered opportunities can result in significant profits in an investment landscape frequently controlled by well-known giants. These three obscure stocks have the potential to provide imp
Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish
09:01pm, Wednesday, 20'th Mar 2024
Vistagen Therapeutics has proprietary platform technologies for developing innovative drugs for mental health disorders. The company's pipeline includes candidates for social anxiety disorder, major d
Why VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety Treatments
03:07am, Sunday, 17'th Mar 2024
VistaGen Therapeutics is developing CNS drugs for anxiety, depression, and other disorders, with Fasedienol in phase 3 clinical trials. Fasedienol has advantages as a non-systemic, low-abuse anxiolyti
This overlooked corner of women's health could be a $350 billion market opportunity
02:33pm, Friday, 15'th Mar 2024
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
Vistagen to Present at Stifel 2024 Virtual CNS Days
08:30am, Monday, 11'th Mar 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals a
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
08:30am, Wednesday, 28'th Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals a
Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?
10:56am, Wednesday, 21'st Feb 2024
The mean of analysts' price targets for VistaGen Therapeutics, Inc. (VTGN) points to a 160% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agree
3 Revolutionary Biotech Stocks Poised for 10X Surge
12:24pm, Monday, 19'th Feb 2024
Investing in high-potential biotech stocks should catapult your portfolio to new heights. Picture this: a global biotech market valued at a whopping $1.55 trillion in 2023 is set to catapult to $3.08
